STXS has 36-month beta value of 1.34. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for STXS is 69.46M, and currently, short sellers hold a 1.33% ratio of that float. The average trading volume of STXS on April 25, 2024 was 307.69K shares.
STXS) stock’s latest price update
The stock of Stereotaxis Inc (AMEX: STXS) has decreased by -7.03 when compared to last closing price of 2.56. Despite this, the company has experienced a -7.75% fall in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-22 that ST. LOUIS, April 22, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 first quarter on Monday, May 13, 2024 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m.
STXS’s Market Performance
Stereotaxis Inc (STXS) has experienced a -7.75% fall in stock performance for the past week, with a -2.86% drop in the past month, and a 13.33% rise in the past quarter. The volatility ratio for the week is 6.03%, and the volatility levels for the past 30 days are at 7.05% for STXS. The simple moving average for the past 20 days is -13.30% for STXS’s stock, with a 22.43% simple moving average for the past 200 days.
Analysts’ Opinion of STXS
Many brokerage firms have already submitted their reports for STXS stocks, with ROTH MKM repeating the rating for STXS by listing it as a “Buy.” The predicted price for STXS in the upcoming period, according to ROTH MKM is $5 based on the research report published on January 10, 2024 of the current year 2024.
Aegis Capital, on the other hand, stated in their research note that they expect to see STXS reach a price target of $6. The rating they have provided for STXS stocks is “Buy” according to the report published on July 12th, 2022.
B. Riley Securities gave a rating of “Buy” to STXS, setting the target price at $6 in the report published on June 23rd of the previous year.
STXS Trading at -12.01% from the 50-Day Moving Average
After a stumble in the market that brought STXS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.66% of loss for the given period.
Volatility was left at 7.05%, however, over the last 30 days, the volatility rate increased by 6.03%, as shares sank -4.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.82% lower at present.
During the last 5 trading sessions, STXS fell by -7.75%, which changed the moving average for the period of 200-days by +60.81% in comparison to the 20-day moving average, which settled at $2.74. In addition, Stereotaxis Inc saw 36.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STXS starting from Isaac Paul J, who purchase 11,060 shares at the price of $1.72 back on Dec 15 ’23. After this action, Isaac Paul J now owns 2,739,693 shares of Stereotaxis Inc, valued at $19,023 using the latest closing price.
Isaac Paul J, the Director of Stereotaxis Inc, purchase 2,808 shares at $1.56 during a trade that took place back on Nov 30 ’23, which means that Isaac Paul J is holding 2,728,633 shares at $4,380 based on the most recent closing price.
Stock Fundamentals for STXS
Current profitability levels for the company are sitting at:
- -0.82 for the present operating margin
- 0.56 for the gross margin
The net margin for Stereotaxis Inc stands at -0.77. The total capital return value is set at -0.76. Equity return is now at value -76.93, with -43.46 for asset returns.
Based on Stereotaxis Inc (STXS), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -1.66. The debt to equity ratio resting at 0.25. The interest coverage ratio of the stock is 50.55.
Currently, EBITDA for the company is -21.24 million with net debt to EBITDA at 0.68. When we switch over and look at the enterprise to sales, we see a ratio of 6.75. The receivables turnover for the company is 7.0for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.50.
Conclusion
To put it simply, Stereotaxis Inc (STXS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
